Prism Medico returns to profit as revenue falls to Rs 18.48 lakh

Prism Medico and Pharmacy Limited reported a Rs 22.65 lakh net profit for the quarter ended 30 September 2026, reversing a Rs 8.48 lakh loss a year earlier, although revenue from operations fell to Rs 18.48 lakh from Rs 50.23 lakh. Other income rose to Rs 26.19 lakh, exceeding operating revenue in the quarter.

Why did Prism Medico return to profit in September 2026?

Prism Medico returned to profit because total income of Rs 44.67 lakh exceeded total expenses of Rs 22.02 lakh in the quarter ended 30 September 2026, resulting in profit before tax and net profit of Rs 22.65 lakh. The unaudited standalone result recorded no current or deferred tax expense for the quarter.

In the quarter ended 30 September 2025, Prism Medico reported total income of Rs 31.90 lakh and total expenses of Rs 60.38 lakh, producing a Rs 8.48 lakh loss. The reported bottom line therefore improved by Rs 31.13 lakh year on year, while total expenses declined by Rs 38.36 lakh.

The income mix changed between the two September quarters. Other income increased by Rs 24.52 lakh from Rs 1.67 lakh, while revenue from operations decreased by Rs 31.75 lakh from Rs 50.23 lakh. Other income accounted for more than half of Prism Medico’s Rs 44.67 lakh total income in the latest quarter.

How much did Prism Medico’s operating revenue decline?

Prism Medico’s revenue from operations fell by Rs 31.75 lakh, or 63.2%, to Rs 18.48 lakh in the quarter ended 30 September 2026 from Rs 50.23 lakh in the corresponding quarter a year earlier. The company reported no operating revenue in the immediately preceding quarter ended 30 June 2026.

The September quarter’s Rs 18.48 lakh of operating revenue made up all revenue from operations reported for the half year ended 30 September 2026. In the corresponding half year ended 30 September 2025, operating revenue was Rs 63.19 lakh, meaning the latest first-half operating revenue was lower by Rs 44.71 lakh.

Other income was Rs 35.25 lakh in the half year ended 30 September 2026, compared with Rs 1.65 lakh in the corresponding prior-year period. This lifted total income to Rs 53.73 lakh, compared with Rs 64.84 lakh a year earlier, despite the decline in operating revenue.

Which expenses changed in Prism Medico’s September quarter?

Prism Medico’s total expenses declined to Rs 22.02 lakh in the September 2026 quarter from Rs 60.38 lakh a year earlier, principally because cost of materials consumed fell to Rs 11.21 lakh from Rs 45.35 lakh. Other expenses also decreased to Rs 8.74 lakh from Rs 13.45 lakh.

Employee benefit expense moved higher, rising to Rs 2.01 lakh from Rs 1.20 lakh in the year-earlier quarter. Depreciation and amortisation expense was Rs 6,000, compared with Rs 10,000, while no finance cost was recorded in September 2026 against Rs 28,000 in September 2025.

Compared with the quarter ended 30 June 2026, total expenses increased by Rs 7.12 lakh from Rs 14.90 lakh to Rs 22.02 lakh. However, total income increased by Rs 35.61 lakh from Rs 9.06 lakh, changing a Rs 5.84 lakh June-quarter loss into the Rs 22.65 lakh September-quarter profit.

What do Prism Medico’s half-year results show?

Prism Medico reported net profit of Rs 16.81 lakh for the half year ended 30 September 2026, compared with a Rs 6.58 lakh loss in the corresponding half year ended 30 September 2025. The first-half result combines the Rs 5.84 lakh loss in the June 2026 quarter with the Rs 22.65 lakh profit in the September 2026 quarter.

First-half total expenses fell to Rs 36.92 lakh from Rs 71.42 lakh a year earlier, a reduction of Rs 34.50 lakh. Cost of materials consumed declined to Rs 11.21 lakh from Rs 44.85 lakh, while other expenses were broadly unchanged at Rs 21.76 lakh, compared with Rs 21.72 lakh in the prior-year half year.

Profit before tax was also Rs 16.81 lakh for the six months ended 30 September 2026 because Prism Medico reported no exceptional item or tax expense in that period. The corresponding prior-year half-year loss before tax was Rs 6.58 lakh, and the filing reported a single operating segment under Indian Accounting Standard 108.

What changed in Prism Medico’s financial position and cash flow?

Prism Medico reported total assets of Rs 33.29 crore at 30 September 2026, compared with Rs 15.61 crore at 31 March 2026. Equity share capital increased to Rs 13.56 crore from Rs 6.06 crore, while other equity was Rs 17.02 crore at the September reporting date versus Rs 9.35 crore at the March year-end.

The statement of assets and liabilities recorded Rs 2.50 crore as money received against share warrants at 30 September 2026. Trade receivables were Rs 3.92 crore, compared with Rs 3.61 crore at 31 March 2026, and other current assets rose to Rs 2.29 crore from Rs 1.08 crore.

The half-year cash-flow statement reported net cash used in operating activities of Rs 93.80 lakh and net cash generated from financing activities of Rs 17.50 crore. It listed Rs 15.00 crore from issuance of share capital warrants and Rs 2.50 crore from issuance of shares, taking cash and cash equivalents to Rs 16.63 crore at 30 September 2026 from Rs 6.37 lakh at the start of the period.

Conclusion

Prism Medico’s September-quarter profit reversal was supported by lower expenses and a substantial increase in other income, rather than by operating revenue growth. Revenue from operations fell to Rs 18.48 lakh, while Rs 26.19 lakh of other income helped total income reach Rs 44.67 lakh and exceed the Rs 22.02 lakh expense base.

What to watch next is the composition of the Rs 26.19 lakh quarterly other income and the eventual treatment of the Rs 2.50 crore recorded as money received against share warrants. The filing does not provide a breakdown of the other income or further terms for the warrants, while it identifies Prism Medico as a single operating segment without segment-level disclosure.